London · Delayed Price · Currency is GBP · Price in USD VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of GBP 3.67 million. The enterprise value is 1.12 million.
| Market Cap | 3.67M |
| Enterprise Value | 1.12M |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.78M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +84.51% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 8.01% |
| Float | 2.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.78 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.23 |
| EV / Sales | 10.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.44 |
| Quick Ratio | 1.75 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -881.08 |
Financial Efficiency
Return on equity (ROE) is -51.07% and return on invested capital (ROIC) is -206.48%.
| Return on Equity (ROE) | -51.07% |
| Return on Assets (ROA) | -132.52% |
| Return on Invested Capital (ROIC) | -206.48% |
| Return on Capital Employed (ROCE) | -255.38% |
| Weighted Average Cost of Capital (WACC) | 9.18% |
| Revenue Per Employee | 8,116 |
| Profits Per Employee | -70,128 |
| Employee Count | 13 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VivoSim Labs has paid 1,486 in taxes.
| Income Tax | 1,486 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.86% in the last 52 weeks. The beta is 1.13, so VivoSim Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -74.86% |
| 50-Day Moving Average | 5.35 |
| 200-Day Moving Average | 10.99 |
| Relative Strength Index (RSI) | 38.65 |
| Average Volume (20 Days) | 9,214 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VivoSim Labs had revenue of GBP 105,506 and -911,661 in losses. Loss per share was -0.40.
| Revenue | 105,506 |
| Gross Profit | -3.63M |
| Operating Income | -8.51M |
| Pretax Income | -910,175 |
| Net Income | -911,661 |
| EBITDA | -8.34M |
| EBIT | -8.51M |
| Loss Per Share | -0.40 |
Balance Sheet
The company has 3.19 million in cash and 603,316 in debt, with a net cash position of 2.58 million.
| Cash & Cash Equivalents | 3.19M |
| Total Debt | 603,316 |
| Net Cash | 2.58M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.30M |
| Book Value Per Share | 1.27 |
| Working Capital | 2.65M |
Cash Flow
| Operating Cash Flow | -7.89M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -8,066.20% |
| Pretax Margin | -862.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.51% |
| Shareholder Yield | -84.51% |
| Earnings Yield | -24.84% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 19, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Aug 19, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |